Skip to main navigation Skip to search Skip to main content

A Phase II Study of Bendamustine + Rituximab With or Without Navitoclax (ABT-263) In Subjects With Relapsed Diffuse Large B-Cell Lymphoma

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date09/15/11 → 09/14/12

Funding

  • Genentech Incorporated: $8,000.00